bluebird bio (BLUE) PT Raised to $200 at Maxim Group; De-Risked
Tweet Send to a Friend
Maxim Group raised its price target on bluebird bio (NASDAQ: BLUE) to $200.00 (from $170.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
